2,4-diacetamido-2,4,6-trideoxy-␣-D-glucopyranose (2,4-diacetamido-Bac) at the reducing end of the glycan (23) . The Nlinked system includes an oligosaccharide transferase that resembles that of eukaryotes, and it has been characterized biochemically (2, 3, 7, 11, 15, 21) . The phenotype of C. jejuni mutants defective in the N-linked system is pleiotropic, likely reflecting the variety of proteins glycosylated by this system. Although fully motile (19) , mutants defective in N-linked glycosylation have a reduced ability to invade intestinal epithelial cells in vitro (19) , reduced levels of colonization in animals (6, 19) , and a significant reduction in natural transformability (9) .
Synthesis of Pse5Ac7Ac and 2,4-diacetamido-Bac begins with the modification of UDP-GlcNAc by distinct pairs of dehydratase/aminotransferase enzymes (17) . These are Cj1293 (PseB) and Cj1294 (PseC) for the Pse5Ac7Ac pathway and Cj1120c (PglF) and Cj1121c (PglE) for the 2,4-diacetamidoBac pathway (17) . PseB has C4,6 dehydratase/C5 epimerase activity that results in the production of UDP-2-acetamido-2,6-dideoxy-␤-L-arabino-hexos-4-ulose, which is the substrate for the second of the enzyme pair, PseC, an aminotransferase which produces UDP-4-amino-4,6-dideoxy-␤-L-AltNAc. Upon accumulation of the UDP-arabino-ketone product, it was demonstrated that the PseB enzyme can also perform a second epimerization, which results in the production of UDP-2-acetamido-2,6-dideoxy-␣-D-xylo-hexos-4-ulose (17) (Fig. 1) . The latter sugar is also the product of PglF, a UDP-␣-D-GlcNAc C6 dehydratase (17; Fig. 1 ). A recent metabolomic study confirmed the accumulation of UDP-2,4-diacetamido-Bac in a pseC mutant in vivo (14) . The accumulation of this intermediate led us to determine whether a pseC mutation could suppress pglF by supplying the missing intermediate in the pgl pathway (see Fig. 1 ).
A double mutant of 81-176 was constructed by transformation of the pglF::aph3 (19) gene into 81-176 pseC::cat (5). The construction was confirmed by PCR analysis using primers that bracketed the insertion point of aph3 into pglF (data not shown). The original pglF::aph3 mutant was fully motile (19) , but the double mutant, like the pseC::cat parent (4), was nonmotile (data not shown). Figure 2 shows that loss of glycosylation in the pglF mutant resulted in reduced reactivity with soybean agglutinin (SBA), which binds to terminal GalNAc residues (7), compared to those for wild-type 81-176 and the pseC mutant. Lectin reactivity appeared to be restored to the wild-type pattern in the pglF pseC double mutant (lane 3), consistent with a restoration of N-linked glycosylation (7, 19) .
In order to study this apparent suppression in more detail, we examined glycosylation of two unrelated proteins directly. VirB10, a periplasmic component of a plasmid-encoded type IV secretion system in 81-176, has been shown experimentally to contain two sites of N-linked glycosylation (9) . In wild-type 81-176 and the pseC mutant, VirB10 migrates as a doublet that represents glycosylation at one or two sites (9) (Fig. 3) . In pglF, VirB10 runs at the predicted mass of the unglycosylated protein; in a pglF pseC double mutant, VirB10 migrates at a position consistent with either no glycosylation or glycosylation at a single site (Fig. 3) . The consensus site for N-linked glycosylation has recently been defined (8) , and CmeC (Cj0365c), an outer membrane component of an efflux pump (10) , is predicted to have two sites of N-linked glycosylation. As shown in Fig. 3 , in wild-type 81-176 and the pseC mutant, a single band is visible in immunoblots with anti-CmeC antiserum. However, in the pglF mutant, the CmeC band migrates more rapidly, consistent with the loss of glycosylation. In the double mutant, there are three bands. One corresponds to the band seen in pglF (unglycosylated), one is comparable to that of the wild type (fully glycosylated), and one is intermediate in size (one glycosylation site). Thus, in the wild type, CmeC appears to be glycosylated at two sites; in the double mutant, there appears to be a mixture, with one, two, or no sites glycosylated.
Mutants in the pgl glycosylation system are defective in natural transformation (9) . Natural transformation of C. jejuni is dependent on a type II secretion system (22) , and multiple components of this secretion system have potential sites for N-linked glycans (8) . Table 1 compares the natural transformation frequencies of wild-type 81-176 with those of the mutants. There was a significant difference between results for the wild type and for the pglF mutant (P Ͻ 0.05), as previously reported for other pgl mutants (9) , and there was no difference between results for the wild type and the pseC mutant. The transformation frequency of the pglF pseC double mutant was higher than that of the pglF mutant but did not reach the level seen with the wild type.
PglF and PseB belong to a family of dehydratases that can be divided into two subfamilies. The first subfamily, which includes PglF and WbpM, consists of large proteins associated with the inner membrane of the cell (1). Thus, it is likely that the biosynthesis of the 2,4-diacetamido-Bac is closely associated with the cytoplasmic face of the inner membrane. Additionally, 2,4-diacetamido-Bac is transferred onto a membraneassociated lipid carrier by PglC (2). In contrast, PseB belongs to the second subfamily of dehydratase enzymes, whose members are smaller than and lack the membrane-anchoring domain associated with the first subfamily. This difference in cellular localization may contribute in part to the inability of PseB to supply sufficient precursor to the pgl system to fully glycosylate N-linked proteins in C. jejuni.
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